Maria Luisa Biondi

Circa Diatech Pharmacogenetics

Questo autore non ha riempito alcun dettaglio.
Finora Diatech Pharmacogenetics ha creato 1081 post nel blog.

1 10, 2016

Daniela Furlan et al., Detection of early genetic and epigenetic alterations in NSCLC by using mass spectrometry and pyrosequencing analysis. Annals of Oncology

Diatech Pharmacogenetics2017-08-07T15:35:26+02:00

22 09, 2016

Andrea Botticelli et al., Degradation Rate of 5-Fluorouracil in Metastatic Colorectal Cancer: A New Predictive Outcome Biomarker? PLOS One

Diatech Pharmacogenetics2017-08-08T12:45:17+02:00

31 08, 2016

Giuseppe Aprile et al., Comparison of the molecular profile of brain metastases from colorectal cancer and corresponding primary tumors. Future Oncology

Diatech Pharmacogenetics2017-08-07T11:28:17+02:00

30 08, 2016

Giorgia Gurioli et al., Methylation pattern analysis in prostate cancer tissue: identification of biomarkers using an MS-MLPA approach. Journal of Translational Medicine

Diatech Pharmacogenetics2017-08-08T12:44:23+02:00

30 08, 2016

Lorenzo Gerratana et al., Real-time tests of multiple genome alterations take the first steps into the clinic: a learning example. Onco Targets and Therapy

Diatech Pharmacogenetics2017-08-07T11:23:58+02:00

23 08, 2016

Incontro con le Aziende del territorio: un’opportunità per Università e Studenti

Diatech Pharmacogenetics2017-08-21T10:29:28+02:00

21 08, 2016

Roberto Moretto et al., Location of Primary Tumor and Benefit From Anti-Epidermal Growth Factor Receptor Monoclonal Antibodies in Patients With RAS and BRAF Wild-Type Metastatic Colorectal Cancer. The Oncologist

Diatech Pharmacogenetics2017-08-07T11:47:42+02:00

26 07, 2016

“PrInT-Age” Un approccio integrato per la promozione della salute degli anziani e delle persone fragili: prevenzione delle infezioni, integrazione nutrizionale e terapie personalizzate

Diatech Pharmacogenetics2017-11-22T12:20:32+01:00

7 07, 2016

Maria Rosaria Raspollini et al., Multiple and bilateral kidney tumors with clear cells of three different histotypes: A case report with clinicopathologic and molecular study. APMIS

Diatech Pharmacogenetics2017-08-07T12:31:35+02:00

7 07, 2016

Andrea Casadei Gardini et al., Efficacy of sorafenib in BRAF-mutated non-small-cell lung cancer (NSCLC) and no response in synchronous BRAF wild type-hepatocellular carcinoma: a case report. BMC Cancer

Diatech Pharmacogenetics2017-08-08T12:42:00+02:00

Precedente 343536 Successivo